BioCentury
ARTICLE | Clinical News

DC Bead: Phase III started

August 13, 2012 7:00 AM UTC

Eisai disclosed in its 1Q12 earnings that it began an open-label, Japanese Phase III trial to evaluate DC Bead in patients with hypervascularized tumors or arteriovenous malformation. Eisai has rights...